chr7-87462827-G-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_000443.4(ABCB4):āc.217C>Gā(p.Leu73Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,613,634 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_000443.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCB4 | NM_000443.4 | c.217C>G | p.Leu73Val | missense_variant | 4/28 | ENST00000649586.2 | NP_000434.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCB4 | ENST00000649586.2 | c.217C>G | p.Leu73Val | missense_variant | 4/28 | NM_000443.4 | ENSP00000496956 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000750 AC: 114AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000716 AC: 180AN: 251316Hom.: 0 AF XY: 0.000677 AC XY: 92AN XY: 135818
GnomAD4 exome AF: 0.00114 AC: 1670AN: 1461446Hom.: 3 Cov.: 31 AF XY: 0.00112 AC XY: 811AN XY: 727042
GnomAD4 genome AF: 0.000749 AC: 114AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000712 AC XY: 53AN XY: 74428
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 28, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 27, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 31, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 73 of the ABCB4 protein (p.Leu73Val). This variant is present in population databases (rs8187788, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with liver disease (PMID: 21119540, 23533021, 29238877). ClinVar contains an entry for this variant (Variation ID: 374521). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ABCB4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
ABCB4-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 06, 2024 | The ABCB4 c.217C>G variant is predicted to result in the amino acid substitution p.Leu73Val. This variant has been reported in the heterozygous state in individuals with intrahepatic cholestasis, primary biliary cirrhosis, and cholelithiasis (Pauli-Magnus et al. 2004. PubMed ID: 14999697; Colombo et al. 2011. PubMed ID: 21119540; Anzivino et al. 2013. PubMed ID: 23022423; Poupon et al. 2013. PubMed ID: 23533021; Degiorgio et al. 2016. PubMed ID: 26324191; Vitale et al. 2018. PubMed ID: 29238877). This variant was also reported, along with a chain-terminating variant in ABCB4, in one individual with low-phospholipid-associated cholelithiasis syndrome (Poupon et al. 2013. PubMed ID: 23533021, Table 1). However, this variant is also reported in 0.13% of alleles in individuals of European (Non-Finnish) descent in gnomAD v2 (as displayed in the table above). However, in gnomAD v4 (available only on GRCh38), this variant is reported in 3 homozygotes, although at a similar frequency (0.14% of alleles in a subpopulation). This population data is not consistent with this variant being a primary cause of disease. Although we suspect that this variant may be benign, the clinical significance of this variant is classified as uncertain at this time due to insufficient functional and genetic evidence. - |
Cholestasis, intrahepatic, of pregnancy, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Progressive familial intrahepatic cholestasis type 3;C2609268:Low phospholipid associated cholelithiasis;C3554241:Cholestasis, intrahepatic, of pregnancy, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 05, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at